๐Ÿ•ต๏ธ Moleculin Biotech, Inc. ($MBRX)

SEC insider & ownership activity, last 12 months ยท CIK 1659617 ยท every row links its SEC filing

Insiders were quiet over the last 12 months โ€“ no open-market buys or sells. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Reg FD disclosure (7.01)Jun 30, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 30, 2026 filing โ†—
Reg FD disclosure (7.01)Jun 30, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 30, 2026 filing โ†—
Reg FD disclosure (7.01)Jun 5, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Jun 5, 2026 filing โ†—
Reg FD disclosure (7.01)May 29, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 29, 2026 filing โ†—
Reg FD disclosure (7.01)May 26, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 26, 2026 filing โ†—
Reg FD disclosure (7.01)May 22, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 22, 2026 filing โ†—
Earnings (2.02)May 15, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 15, 2026 filing โ†—
Reg FD disclosure (7.01)May 13, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 13, 2026 filing โ†—
Reg FD disclosure (7.01)May 12, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 12, 2026 filing โ†—
Reg FD disclosure (7.01)May 8, 2026 filing โ†—
Financial Statements and Exhibits (9.01)May 8, 2026 filing โ†—
Reg FD disclosure (7.01)Apr 23, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Apr 23, 2026 filing โ†—
Shareholder vote (5.07)Apr 15, 2026 filing โ†—
Reg FD disclosure (7.01)Mar 23, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 23, 2026 filing โ†—
Reg FD disclosure (7.01)Mar 19, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 19, 2026 filing โ†—
Earnings (2.02)Mar 19, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 19, 2026 filing โ†—
Material agreement (1.01)Feb 19, 2026 filing โ†—